Inhibition of insulin degradation by insulin-like growth factors I and II in human hepatoma (HepG2) cells
- 1 August 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in Acta Endocrinologica
- Vol. 121 (2) , 279-285
- https://doi.org/10.1530/acta.0.1210279
Abstract
IGF-I infused at pharmacological doses in healthy men markedly decreases C-peptide levels, whereas insulin levels remain within the normal range. One possible explanation is decreased insulin removal. As the liver is the major site of insulin degradation, we studied insulin degradation by HepG2 cells in the presence of IGF. We found that IGF-I at a concentration of 130 nmol/l inhibits insulin degradation by HepG2 cells when the initial insulin concentration is 0.34 nmol/l. The effect of IGF-I on insulin degradation is dose-dependent and the rate of insulin degradation is dependent on the insulin concentration. IGF-II is 6 to 10 times more potent than IGF-I in inhibiting 125I-insulin binding to HepG2 cells and in protecting insulin from being degraded. Thus, IGF-I and IGF-II inhibit insulin degradation most likely by competing for binding at insulin binding sites of liver cells.This publication has 18 references indexed in Scilit:
- Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease.Proceedings of the National Academy of Sciences, 1986
- The somatomedin-binding protein isolated from a human hepatoma cell line is identical to the human amniotic fluid somatomedin-binding proteinBiochemical and Biophysical Research Communications, 1985
- Dual regulation of glycogen metabolism by insulin and insulin-like growth factors in human hepatoma cells (HEP-G2). Analysis with an anti-receptor monoclonal antibody.Journal of Clinical Investigation, 1984
- Degradation Of Insulin-Like Growth Factors I And II By A Human Insulin Degrading EnzymeEndocrine Research, 1984
- Resistance to subcutaneous and intramuscular insulin associated with deficiency of insulin-like growth factor (IGF) 2Metabolism, 1983
- Demonstration that a Human Hepatoma Cell Line Produces a Specific Insulin-Like Growth Factor Carrier Protein*Journal of Clinical Endocrinology & Metabolism, 1983
- Identification of Insulin-Degrading Enzyme on the Surface of Cultured Human Lymphocytes, Rat Hepatoma Cells, and Primary Cultures of Rat Hepatocytes*Endocrinology, 1982
- The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin.Journal of Biological Chemistry, 1978
- Evidence that Somatomedin-C Is Degraded by the Kidney and Inhibits Insulin DegradationEndocrinology, 1977
- Removal of Fatty Acids from Serum Albumin by Charcoal TreatmentJournal of Biological Chemistry, 1967